OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
60
Results
Show all
Save search
Copy query
Show results for
Unknown
(53)
Proteomics
(3)
Transcriptomics
(2)
Metabolomics
(2)
Organisms
Oryza sativa
(1)
Setaria italica
(1)
Homo sapiens
(1)
Pseudomonas aeruginosa PAO1
(1)
Algoriphagus machipongonensis
(1)
Echinicola pacifica
(1)
Salpingoeca rosetta
(1)
Repository
biostudies-arrayexpress
(2)
iProX
(2)
MetaboLights
(2)
pride
(1)
Technology Type
Mass spectrometry
(1)
Mass spectrometry assay
(1)
Affinity purification coupled with mass spectrometry proteomics
(1)
Mass Spectrometry
(1)
Instrument Platform
Liquid Chromatography MS - alternating - reverse-phase
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2012
(1)
2011
(1)
2024
(1)
2020
(1)
2026
(1)
2025
(1)
2022
(1)
CHEBI ID
CHEBI:16856
(1)
CHEBI:16914
(1)
CHEBI:17189
(1)
CHEBI:17964
(1)
CHEBI:193350
(1)
CHEBI:23673
(1)
CHEBI:25094
(1)
CHEBI:36281
(1)
Metabolite Name
Caffeic acid
(1)
Diaminopimelic acid
(1)
Ferulic acid
(1)
Gentisic acid
(1)
Glutathione
(1)
Lysine
(1)
Pipecolic acid
(1)
Salicylic acid
(1)
Study type
RNA-seq of coding RNA
(1)
RNA-seq of non coding RNA
(1)
Release Date
2025
(16)
2023
(8)
2022
(7)
2024
(5)
2012
(3)
2020
(3)
2019
(3)
2015
(3)
2021
(2)
2016
(2)
2011
(1)
2026
(1)
2017
(1)
Lab affiliation
Department of Molecular and Applied Microbiology Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena (Leibniz-HKI) Jena, Germany
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Metabolomic profiling reveals pipecolic acid-related pathways involved in Rlm1-mediated resistance in Canola
Study of pipecolic acid-related pathways involved in Rlm1-mediated resistance in Canola
2025-07-04
|
MTBLS12542
|
MetaboLights
Cite
Metabolomics of human primary B-ALL cells treated by BCR-Abl1 inhibitor, STI571, and p190 BCR-Abl+ BAF3 cells with ASS1 knockdown
Analyze the Metabolomics changes in B-ALL cells after the treatment of imatinib and p190+ BAF3 cells with ASS1 knockdown or left untreated. two methods as the below LC-MS description showed were used.
2026-07-08
|
MTBLS14638
|
MetaboLights
Cite
An immune and epithelial-mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas.
Not available
S-EPMC9909968
|
biostudies-literature
Cite
Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma.
Not available
S-EPMC10904238
|
biostudies-literature
Cite
Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity.
Not available
S-EPMC9768347
|
biostudies-literature
Cite
Development and validation of a prognostic model and gene co-expression networks for breast carcinoma based on scRNA-seq and bulk-seq data.
Not available
S-EPMC9843357
|
biostudies-literature
Cite
Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma.
Not available
S-EPMC7542239
|
biostudies-literature
Cite
The Scaphoid Safe Zone: A Radiographic Simulation Study to Prevent Cortical Perforation Arising from Different Views.
Not available
S-EPMC5256911
|
biostudies-literature
Cite
Extracellular Vesicle-Derived circITGB1 Regulates Dendritic Cell Maturation and Cardiac Inflammation via miR-342-3p/NFAM1.
Not available
S-EPMC9126660
|
biostudies-literature
Cite
Three-dimensional distribution of cystic lesions in osteonecrosis of the femoral head.
Not available
S-EPMC7231955
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
